Uxin trades up on debut after $225m US IPO
Chinese used car trading platform Uxin Group gained 10% on its first day of trading on NASDAQ following a $225 million IPO that was scaled back in terms of size and pricing.
The company sold 25 million American Depository Shares (ADS) at $9.00 apiece, according to a filing. It initially sought to sell 38 million shares with a target pricing range of $10.50-12.50. The stock...
More on Greater China
Latest News
Corporate VCs & climate change: Good citizens
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Panacea leads $40m Series C for China's XWPharma
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Tencent backs Chinese healthcare cloud services platform
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Chinese mouse-based drug testing specialist raises $143m
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.